Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional Study to Generate Real-World Evidence on the Cardiovascular Safety of CONTRAVE® in the United States (U.S.)

NCT06090461 is registered in ClinicalTrials.gov with Currax Pharmaceuticals as lead sponsor.

NCT NCT06090461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06090461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional Study to Generate Real-World Evidence on the Cardiovascular Safety of CONTRAVE® in the United States (U.S.)
Lead sponsor
Currax Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
December 31, 2022
Enrollment
31,889 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity